Integrin mobilizes intracellular Ca2+ in renal vascular smooth muscle cells

Wah-Lun Chan1, N.-H. Holstein-Rathlou2, and Kay-Pong Yip3

1 Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, Rhode Island 02912; 3 Department of Physiology and Biophysics, University of South Florida, Tampa, Florida 33612; and 2 Department of Medical Physiology, The University of Copenhagen, DK-2200 Copenhagen N, Denmark


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Peptides with the Arg-Gly-Asp (RGD) motif induce vasoconstriction in rat afferent arterioles by increasing the intracellular Ca2+ concentration ([Ca2+]i) in vascular smooth muscle cells (VSMC). This finding suggests that occupancy of integrins on the plasma membrane of VSMC might affect vascular tone. The purpose of this study was to determine whether occupancy of integrins by exogenous RGD peptides initiates intracellular Ca2+ signaling in cultured renal VSMC. When smooth muscle cells were exposed to 0.1 mM hexapeptide GRGDSP, [Ca2+]i rapidly increased from 91 ± 4 to 287 ± 37 nM and then returned to the baseline within 20 s (P < 0.05, 34 cells/5 coverslips). In controls, the hexapeptide GRGESP did not trigger Ca2+ mobilization. Local application of the GRGDSP induced a regional increase of cytoplasmic [Ca2+]i, which propagated as Ca2+ waves traveling across the cell and induced a rapid elevation of nuclear [Ca2+]i. Spontaneous recurrence of smaller-amplitude Ca2+ waves were found in 20% of cells examined after the initial response to RGD-containing peptides. Blocking dihydropyridine-sensitive Ca2+ channels with nifedipine or removal of extracellular Ca2+ did not inhibit the RGD-induced Ca2+ mobilization. However, pretreatment of 20 µM ryanodine completely eliminated the RGD-induced Ca2+ mobilization. Anti-beta 1 and anti-beta 3-integrin antibodies with functional blocking capability simulate the effects of GRGDSP in [Ca2+]i. Incubation with anti-beta 1- or beta 3-integrin antibodies inhibited the increase in [Ca2+]i induced by GRGDSP. We conclude that exogenous RGD-containing peptides induce release of Ca2+ from ryanodine-sensitive Ca2+ stores in renal VSMC via integrins, which can trigger cytoplasmic Ca2+ waves propagating throughout the cell.

confocal microscopy; immunofluorescence; calcium; wave


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

THE ARG-GLY-ASP (RGD) motif is a common motif found in many extracellular matrix proteins that bind to integrins. RGD-containing peptides induce vasodilatation in cremaster muscle arterioles by lowering the intracellular Ca2+ concentration ([Ca2+]i; see Ref. 8). L-type Ca2+ channels (24), K+ channels (18), and alpha vbeta 3-integrins were suggested to be involved (15). However, alpha 5beta 1-integrins mediate an increase of the Ca2+ current in smooth muscle cells isolated from the same vascular bed (24). In rat renal afferent arterioles, RGD-containing peptides induce vasoconstriction rather than dilatation. The constriction is associated with a pronounced increase in the [Ca2+]i in the smooth muscle cells as measured by confocal fluorescence microscopy (27). The [Ca2+]i in renal vascular smooth muscle is the major determinant in the myogenic mechanism of renal autoregulation (19), in which renal arterioles constrict when the transmural pressure is increased. Extracellular mechanical stimuli can be transduced into the cytosol via interactions between the cytoskeleton and the cytoplasmic domain of integrins (23). It is hypothesized that variations of transmural pressure in renal arterioles will alter the interactions between integrins and the extracellular matrix, which contributes to the mechanotransduction in renal autoregulation (20, 27). It has been demonstrated that the myogenic component in renal autoregulation is oscillating at 0.1-0.2 Hz (4, 25). These oscillations can be driven by a temporally and spatially coordinated release of intracellular Ca2+ in the form of Ca2+ wave or [Ca2+]i oscillation in afferent arteriolar vascular smooth muscle. [Ca2+]i oscillation can be considered as a recurrence of fast-propagating intracellular Ca2+ waves. We hypothesized that occupancy of integrins would trigger spatial and temporal variations of [Ca2+]i in afferent arteriolar vascular smooth muscle cells. The present study was performed to test these hypotheses in cultured renal vascular smooth muscle cells using confocal fluorescence microscopy.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Isolation and culture of rat renal preglomerular smooth muscle cells. Renal preglomerular smooth muscle cells were isolated from Sprague-Dawley rats by an iron oxide sieving method (10, 13, 29). Briefly, rats were anesthetized with halothane and laparotomized, and the kidneys were exposed. The abdominal aorta distal to the renal arteries was cannulated, and 1% iron oxide (Fe3O4) in calcium-free Hanks' balanced salts solution (HBSS) was perfused into the kidney. The kidneys were then removed, and the cortex was harvested. The tissue was minced and transferred to HBSS. Iron oxide-containing tissue was isolated from the suspension with a side-pull magnet (Perseptive Diagnostics) and was resuspended in HBSS. The suspension was passed through needles of decreasing size (18, 20, and 23 G) and was filtered on a 200-mesh sieve (Sigma). The iron oxide-containing tissue on the sieve was then digested with collagenase (type 1, 2 mg/ml; Worthington) in HBSS (with calcium chloride) at 37°C with gentle shaking for 30 min. The remaining iron oxide-containing tissue was removed by a magnetic method, and smooth muscle cells in the supernatant were centrifuged down and resuspended in 10 ml of DMEM with 10% FBS. The cells were seeded onto collagen I-coated T25 culture flasks (Becton-Dickinson) and incubated at 37°C in 5% CO2 and 95% air at 98% humidity. The cells were allowed to seed for 2 days before the medium was changed. The medium was changed every 2-3 days until the cells had grown to confluence. The cells were passed approximately every 5 days and were passed onto collagen I-coated coverslips (Becton-Dickinson) during the sixth passage. Cells were grown close to confluence for the immunohistochemistry and Ca2+ measurement studies. Cells from at least three different preparations (rats) were studied in each experimental protocol.

Measurement of [Ca2+]i in cultured renal smooth muscle cells. The [Ca2+]i of cultured renal preglomerular smooth muscle cells grown on coverslips was measured with fluo 3 from the fluorescence images acquired with an MRC-1000 (Bio-Rad) confocal scanning unit, which was mounted on a Zeiss Axiovert 100TV inverted microscope. Renal preglomerular smooth muscle cells at sixth passage were grown on collagen I-coated coverslips for 3-4 days and used for measurement before they become fully confluent. The cells on the coverslips were loaded with 2 µM of fluo 3-AM (Molecular Probes) in DMEM for 20 min at 37°C. The excess dye was washed away by HBSS (with calcium) and incubated in the same buffer for 15 min. The coverslip was then inserted in the bottom of a perfusion chamber (Vestavia) and mounted on the inverted microscope. The changes in the smooth muscle cell [Ca2+]i were measured at room temperature. Fluorescence was excited with the 488-nm line of the krypton-argon laser. Emission was collected through a band-pass filter 522/32 nm at 1 Hz and stored digitally. All fluorescence images were acquired with a Zeiss plan-apochromat objective [63 × at numeric aperture (NA) 1.4 or 40 × at NA 1.2]. Residence time of the laser on the coverslip is 0.29 s. The changes of [Ca2+]i in each cell after exposure to 0.1 mM of either hexapeptide GRGDSP (Gly-Arg-Gly-Asp-Ser-Pro) or GRGESP (Gly-Arg-Gly-Glu-Ser-Pro) were obtained during the retrospective analysis of the stored fluorescence images with software (Time Course/Ratiometeric Software Module) supplied by Bio-Rad. A testing dose of 0.1 mM of the peptides was chosen so that the increase in fluorescence intensity does not saturate the detector during the image acquisition. A similar dosage was used in smooth muscle cells isolated from cremaster muscle arterioles (24). RGD peptides were administered in the perfusion chamber as a bolus in most studies. RGD peptides were present in the chamber throughout the recording period. When RGD was required to be applied locally on the coverslip, a micropipette (5-10 µm diameter) attached to a microperfusion pump was used (Hampel).

Calibration of fluorescence emission was performed using the nonfluorescent Ca2+ ionophore 4-bromo-A-23187 (10-5 M) in the presence of extracellular Ca2+ to saturate the intracellular dye with Ca2+ and thereby obtain maximal fluorescence (Fmax). The minimal fluorescence (Fmin) was measured after addition of Ca2+-free HBSS containing EGTA (4 mM). Fluorescence intensity (F) was converted to [Ca2+]i using the equation (2).
[Ca<SUP><IT>2+</IT></SUP>]<SUB>i</SUB><IT>=K</IT><SUB>d</SUB>(F<IT>−</IT>F<SUB>min</SUB>)<IT>/</IT>(F<SUB>max</SUB><IT>−</IT>F)
where Kd is the dissociation constant (320 nM; provided by Molecular Probes). Because fluo 3 is a nonratiometric dye, photobleaching and leakage during repeated image acquisitions will render calibrations unreliable. Consequently, calibrations and conversion of the fluorescent signal to [Ca2+]i were only performed in the studies that involved a single exposure of the cells to the RGD-containing peptide.

To determine the role of dihydropyridine-sensitive Ca2+ channels in the RGD-induced increase of [Ca2+]i, smooth muscle cells were incubated with nifedipine (1 µM) at room temperature for 5 min in darkness before exposure to 0.1 mM GRGDSP. To study the effects of depleting extracellular Ca2+ in the RGD-induced elevation of [Ca2+]i, smooth muscle cells were washed three times (3 min each) with Ca2+-free HBSS containing EGTA (4 mM) before GRGDSP was introduced into the perfusion chamber.

To test whether ryanodine-sensitive Ca2+ stores are involved in RGD peptide-induced Ca2+ mobilization, smooth muscle cells were incubated with ryanodine (20 µM) for 20 min in Ca2+-free HBSS before the cells were exposed to GRGDSP. To test whether inositol trisphosphate (IP3)-sensitive Ca2+ stores are involved in RGD-induced Ca2+ mobilization, xestospongin C (50 µM) was used instead of ryanodine.

To test whether the RGD-induced [Ca2+]i elevation is mediated by specific integrins, the cells were incubated with functional blocking anti-beta 1-, or -beta 2-, or -beta 3-integrin antibodies (50 µg/ml) for 20 min before exposure to GRGDSP hexapeptide. Changes in [Ca2+]i during the incubation of anti-integrin were also monitored. beta 2-Integrins are exclusively expressed in leukocytes but not in smooth muscle cells and thus served as negative controls (21).

Immunofluorescence of beta -integrin subunits in cultured smooth muscle cells. To determine whether incubation of functional blocking anti-integrin antibodies induces any redistribution of integrin in the smooth muscle cells, the immunofluorescence of beta 1 and beta 3 was compared when cells were fixed by using two different fixation protocols. First, preglomerular smooth muscle cells grown on collagen I-coated coverslips were fixed in 2% paraformaldehyde for 10 min. The coverslips were blocked with 20% donkey serum in PBS for 60 min and then incubated with a mixture of anti-smooth muscle alpha -actin antibodies and antibodies specific to beta 1- or beta 3-integrin subunits for double-labeling studies. After 2 h of incubation, the sections were washed three times with fresh PBS followed by incubation with the appropriate Cy3- or Cy5-conjugated secondary antibodies for 60 min. Cy3 (indocarbocyanine, absorption peak 550, emission peak 570) and Cy5 (indodicarbocyanine, absorption peak 650, emission peak 670) are cyanine-based fluorophores, which are brighter and more photostable than the widely used fluorescein-based fluorophores. All incubations were carried out in a moistened chamber at room temperature. The coverslips were then rinsed with fresh PBS three times, mounted in Gel/Mount (Fisher), and examined with a confocal microscope. Cultured cells incubated with anti-beta 2-integrin antibodies only were used as negative controls. All antibodies were diluted with PBS containing 20% donkey serum.

To study the effects of anti-integrin antibodies on the distribution of integrins in live cells, a separate study was performed where cultured cells were incubated with functional blocking anti-integrin antibodies (50 µg/ml, beta 1 or beta 3) for 20 min before the fixation with paraformaldehyde. Antibodies were diluted with DMEM in all functional blocking studies.

Antibodies. Mouse monoclonal IgM antibody to beta 3 was purchased from Transduction Laboratories (Lexington, KY). Functional blocking antibodies to beta 1 (hamster, monoclonal IgM, FITC conjugate or nonconjugated)-, beta 2 (mouse, monoclonal IgG)-, and beta 3-integrins (mouse, monoclonal IgG, nonconjugated) were purchased from PharMingen (San Diego, CA). Cy3-conjugated and nonconjugated mouse monoclonal IgG to smooth muscle alpha -actin were purchased from Sigma Chemical (St. Louis, MO). Dilution for all primary antibodies was determined before the experiment. All secondary conjugated antibodies purchased have been solid-phase adsorbed to optimize the signal for the multiple labeling study. Secondary antibodies were diluted at 1:400 for all studies (Jackson Immunoresearch Laboratory).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Effect of RGD-containing peptide on [Ca2+]i. Exposing renal smooth muscle cells loaded with fluo 3 to 0.1 mM hexapeptide GRGDSP in HBSS elicited an immediate increase of fluorescence emission intensity, indicating an elevation of smooth muscle [Ca2+]i. The increase of mean [Ca2+]i reached a peak value of 287.0 ± 37.2 nM from a baseline of 91.4 ± 3.9 nM within 8 s and then returned to baseline within 20 s (P < 0.05, 34 cells/5 coverslips; Fig. 1). There were two types of responses in terms of the change in [Ca2+]i profile in the individual cells. Eighty percent of the cells examined displayed a rapid increase of [Ca2+]i and then simply returned to the baseline level similar to the profile shown in Fig. 1. In 20% of the cells studied, there were recurrences of smaller-amplitude Ca2+ waves after the initial response to the RGD peptide. The propagation of the Ca2+ wave could be visualized by the time delays between the [Ca2+]i increases in the different regions of the cell (Fig. 2). The mean propagation velocity was 24.4 ± 1.7 µm/s (n = 6). As a result of these spontaneous recurrent Ca2+ waves, the mean [Ca2+]i of the whole cell was set to oscillate. Hexapeptide GRGESP (0.1 mM) in HBSS or HBSS alone did not induce any change in [Ca2+]i (Fig. 1). This confirmed our previous observation from isolated afferent arterioles that the increase of smooth muscle [Ca2+]i is triggered by the RGD motif.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 1.   Time course of change in intracellular Ca2+ concentration ([Ca2+]i) when cells were exposed to either 10-4 M of GRGDSP or 10-4 M of GRGESP. The peptide was added to the perfusion chamber at time 0. Dotted lines are SE. , Increase of [Ca2+]i is significant (P < 0.05) compared with the baseline.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   Recurrence of spontaneous Ca2+ waves induced by 10-4 M of GRGDSP. Fluorescence intensity of fluo 3 is measured simultaneously in 6 regions across a single smooth muscle cell. Each sampling region is a 12 µm × 12 µm square. The Ca2+ wave propagates from region 1 to region 6. The peptide is added to the perfusion chamber at time 0 as a bolus. The Ca2+ wave is propagating at 24 µm/s.

Local application of 0.1 mM GRGDSP within the perfusion chamber through a micropipette induced a cytoplasmic Ca2+ wave that propagated across the cells (Fig. 3). The cytoplasmic Ca2+ wave triggered a rapid increase of nuclear [Ca2+]i when it propagated through the nucleus (Fig. 4). The mean Ca2+ wave propagation velocity was 27.6 ± 1.4 µm/s (n = 6), which is not significantly different from the spontaneous recurrent Ca2+ waves. In some occasions, locally induced Ca2+ waves were observed to spread into the adjacent cells.


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 3.   Propagation of Ca2+ wave in a single renal vascular smooth muscle cell. A: projection of 10 images collected before the appearance of Ca2+ wave. Arrow indicates the nucleus. B-L: consecutive images collected at 1 Hz to display the propagation of calcium wave. GRGDSP (0.1 mM) was applied locally on the coverslip with a micropipette.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4.   Reversal of the nucleocytoplasmic Ca2+ gradient when a Ca2+ wave passes through the nucleus in the vascular smooth muscle cell shown in Fig. 3. Fluorescence intensity of fluo 3 is measured simultaneously in three regions, a cytoplasmic region anterior to the nucleus, a nuclear region, and a cytoplasmic region posterior to the nucleus. The area of each region is 12 µm × 12 µm. The Ca2+ wave is propagating at a velocity of 27 µm/s.

Effects of nifedipine and external Ca2+ depletion on [Ca2+]i response. To determine whether the increase of [Ca2+]i triggered by RGD-containing peptides in renal vascular smooth muscle cells is due to an influx of extracellular Ca2+ through voltage-gated dihydropyridine-sensitive Ca2+ channels, the effects of nifedipine on the [Ca2+]i were determined. Smooth muscle cells loaded with fluo 3 were first exposed to 0.1 mM of GRGDSP to confirm that these cells were responding to RGD motifs. The smooth muscle cells were then incubated with nifedipine (1 µM) for 5 min. There was no change in the fluo 3 emission intensity when the cells were exposed to 0.3 M KCl in HBSS, indicating that dihydropyridine-sensitive Ca2+ channels were successfully blocked by nifedipine (data not shown). Incubation with nifedipine did not inhibit the increase of [Ca2+]i induced by GRGDSP or the induction and propagation of Ca2+ waves. The peaks of normalized fluo 3 emission intensity before and after the treatment with nifedipine were 2.04 ± 0.13 and 1.73 ± 0.23, respectively (29 cells/3 coverslips, Fig. 5A).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   Normalized time course of the change in fluo 3 fluorescence intensity when cells were exposed to 10-4 M GRGDSP after incubation with 1 µM nifedipine, 29 cells/3 coverslip (A) or in the absence of extracellular Ca2+, 24 cells/3 coverslips (B). The peptide was added to the perfusion chamber at time 0. Dotted lines are SE. , Fluorescence intensity is significantly different (P < 0.05) from the baseline.

Removal of extracellular Ca2+ from the bathing medium by including 4 mM EGTA in Ca2+-free buffer did not inhibit the increase of [Ca2+]i or the propagation of Ca2+ waves induced by the RGD-containing peptide. The peaks of normalized fluo 3 emission intensity before and after the removal of extracellular Ca2+ were 1.77 ± 0.12 and 1.78 ± 0.19, respectively (24 cells/3 coverslips, Fig. 5B). These observations suggest that the Ca2+ mobilization and propagation of Ca2+ wave do not depend on influx of extracellular Ca2+. However, the increase of [Ca2+]i triggered by RGD peptides in individual cell was not simultaneous. A delayed onset of the [Ca2+]i increase was observed in a substantial number of cells. The variable time courses for the response to the RGD-containing peptide also resulted in an increased variability for the recovery of [Ca2+]i in Fig. 5B. Inclusion of 1 mM Mg2+ in the Ca2+-free solution reduced the heterogeneity in the onset of rising [Ca2+]i (data not shown). These observations are consistent with the observation that binding of RGD motifs to integrins is affected by the extracellular divalent ions (17).

Effects of IP3 receptor blocker and ryanodine on [Ca2+]i response in the absence of extracellular Ca2+. Smooth muscle cells loaded with fluo 3 were first exposed to 0.1 mM of GRGDSP to confirm that these cells were responding to RGD motifs. The smooth muscle cells were incubated with 50 µM xestospongin C for 30 min in the absence of extracellular Ca2+. There was a small transient increase of fluo 3 emission during the first few minutes of incubation, which was most likely due to the inhibiting effect of xestospongin C in endoplasmic reticulum Ca2+ pumps at this concentration (9). There was no change in fluo 3 emission intensity when the cells were exposed to 1 µM of phenylephrine after xestospongin C incubation, which indicated that the IP3 receptors were blocked. However, 0.1 mM of GRGDSP could still induce mobilization of intracellular Ca2+ as reflected in an increase of fluo 3 emission (Fig. 6A). The peaks of normalized fluo 3 emission intensity before and after the incubation of xestospongin C were 1.76 ± 0.06 and 1.52 ± 0.08, respectively (58 cells/4 coverslips). On the contrary, preincubation of 20 µM of ryanodine for 20 min totally abolished the Ca2+ mobilization effect of 0.1 mM of GRGDSP (Fig. 6B). Phenylephrine (1 µM) could induce an increase of fluo 3 emission after the pretreatment of ryanodine. These observations suggest that the Ca2+ mobilization induced by RGD-containing peptides involves the ryanodine-sensitive Ca2+ stores but not the IP3-sensitive Ca2+ stores.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Normalized time course of the change in fluo 3 fluorescence intensity when cells were exposed to 10-4 M GRGDSP after incubation with 50 µM xestospongin C, 58 cells/4 coverslip (A) or after the incubation of 20 µM ryanodine, 106 cells/6 coverslips (B). The peptide was added to the perfusion chamber at time 0. Dotted lines are SE.  and black-triangle, Fluorescence intensity is significantly different (P < 0.05) from the baseline.

Effects of anti-integrin antibodies on the [Ca2+]i of smooth muscle cells. To determine whether the Ca2+ mobilization induced by RGD peptides is mediated by integrins (15), cells loaded with fluo 3 were first exposed to 0.1 mM of GRGDSP to confirm that these cells were responsive to the RGD motifs. The cells were then incubated with functional blocking anti-beta 1-, anti-beta 2-, or anti-beta 3-integrin antibodies for 20 min. Preincubation of the cells with either anti-beta 1- or anti-beta 3-integrin antibodies completely inhibited the elevation of [Ca2+]i induced by GRGDSP (Fig. 7). Anti-beta 2-integrin antibodies did not inhibit the increase of [Ca2+]i induced by GRGDSP (Fig. 8). The latter observation was expected because beta 2-integrins are exclusively expressed in leukocytes (21). These observations suggest that the increase of [Ca2+]i triggered by RGD motifs is mediated by specific binding of RGD-containing peptides to functional beta -integrin and that the interactions are mediated by more than one class of integrin heterodimers. To test whether the ligation of beta 1- and beta 3-integrins by the functional blocking antibodies can trigger Ca2+ mobilization, the changes in emission intensity of fluo 3 were monitored when smooth muscle cells were exposed to these antibodies. Both anti-beta 1- and anti-beta 3-integrin antibodies could induce an increase in [Ca2+]i in smooth muscle cells when applied separately (Fig. 9). During multiple exposure of the smooth muscle cells to the same antibody, an increase of [Ca2+]i was only detected in the first exposure. During sequential application of these two antibodies into the smooth muscle cells, each antibody could induce a rise in [Ca2+]i no matter which antibody was administered first. These observations indicate that these two antibodies ligate two different classes of integrin and that the ligation of either beta 1- or beta 3-integrin alone can mobilize intracellular Ca2+.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 7.   Normalized time course of change in fluo 3 fluorescence intensity when cells were exposed to 10-4 M GRGDSP after incubation with functional blocking anti-beta 1 integrin antibody, 24 cells/4 coverslips (A) or after incubation of functional blocking anti-beta 3-integrin antibody, 27 cells/4 coverslips (B). , Fluorescence intensity is significantly different (P < 0.05) from baseline.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 8.   Normalized time course of change in fluo 3 fluorescence intensity when cells were exposed to 10-4 M GRGDSP before (A) and after (B) incubation with functional blocking anti-beta 2-integrin antibodies (41 cells/3 coverslips). The peptide was added to the perfusion chamber at time 0. Dotted lines are SE.  and black-triangle, Fluorescence intensity is significantly different (P < 0.05) from the baseline.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 9.   Normalized time course of change in fluorescence intensity when cells were exposed to anti-beta 1-integrin antibodies (30 cells/3 coverslips) and anti-beta 3-integrin antibodies (27 cells/3 coverslips). The concentration of antibodies used was 50 µg/ml. The peptide was added to the perfusion chamber at time 0. Dotted lines are SE.  and black-triangle, Fluorescence intensity is significantly different (P < 0.05) from the baseline.

Immunofluorescence of integrin beta -subunits. Figure 10 shows the immunofluorescence after double labeling for beta 1- and alpha -actin. beta 1-Integrin was found mainly along the stress fibers and on the periphery of nuclei. The staining for alpha -actin confirmed that the cells were smooth muscle cells. When functional-blocking anti-beta 1-integrin antibodies were incubated for 20 min with smooth muscle cells before fixation, the immunofluorescence signal of beta 1-integrin along the stress fibres disappeared, and only the signal on the periphery of nuclei remained (Fig. 10, C and D). These observations suggest that incubation with functional-blocking anti-integrin antibodies in living cells induces a redistribution of integrins from the plasma membrane. beta 3-Integrin showed a fibrillar distribution with more signal near the edge of the cells and the periphery of nuclei in controls (Fig. 11A). A redistribution of beta 3-integrin was also found when functional blocking antibodies of beta 3-integrin were incubated with the cultured cells before the cell fixation (Fig. 11C). Treatment of functional blocking anti-beta 1- or anti-beta 3-integrin antibodies before paraformaldehyde fixation did not result in cell detachment. In the controls, no immunofluorescence of beta 2 was detected in the vascular smooth muscle cells as expected (image not shown).


View larger version (135K):
[in this window]
[in a new window]
 
Fig. 10.   Colocalization of beta 1-integrin (A and C) and smooth muscle alpha -actin (B and D) in preglomerular smooth muscle cells. Cellular fixation was performed before (A and B) and after (C and D) incubation with functional-blocking antibodies. In C and D, cells were incubated with functional blocking anti-beta 1-antibodies (hamster monoclonal IgG) for 20 min before fixation. Anti-beta 1-integrin antibody was conjugated to FITC. Anti-alpha -actin antibody was conjugated to Cy3.



View larger version (141K):
[in this window]
[in a new window]
 
Fig. 11.   Colocalization of beta 3-integrin (A and C) and smooth muscle alpha -actin (B and D) in preglomerular smooth muscle cells. Cellular fixation was performed before (A and B) and after (C and D) incubation with functional blocking antibodies. In C and D, cells were incubated with functional blocking anti-beta 3-antibodies (mouse monoclonal IgG) for 20 min before fixation. A mouse monoclonal IgM anti-beta 3-integrin antibody was used to label beta 3-integrin after fixation. Anti-alpha -actin-antibody (mouse monoclonal IgG) was conjugated to Cy3. beta 3-Integrin was visualized with Cy5-conjugated secondary antibody.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The utility of isolated afferent arterioles for studying the subcellular variations of [Ca2+]i is limited by the geometry of blood vessels, where the individual smooth muscle cell wraps around the vessel (26). Refined methodology is now available for isolating vascular smooth muscle cells from preglomerular resistance vessels for acute studies (10, 29). Because of the enzymatic digestion process used in the isolation of the smooth muscle cells, the integrity of integrins on freshly isolated smooth muscle cells might be compromised. We took an alternative approach by culturing preglomerular smooth muscle cells on coverslips so that the subcellular spatial and temporal variations in intracellular Ca2+ could be monitored by confocal fluorescence microscopy. We first demonstrated that exposing the cells to the hexapeptide GRGDSP resulted in an increase of [Ca2+]i. In contrast, no response was observed when the hexapeptide GRGESP was used. These observations are in agreement with previous studies performed in isolated afferent arterioles (27). The baseline [Ca2+]i in the cultured smooth muscle cells is 91 ± 4 nM, which is consistent with reports from another laboratory (29). GRGDSP (0.1 mM) increased the [Ca2+]i to 287 ± 37 nM within 8 s, and the values were restored to the baseline within 20 s. The time-course profile of the [Ca2+]i increase is similar to that in isolated afferent arterioles (27). These observations suggest that the machinery required for RGD-dependent mobilization of intracellular Ca2+ in intact arteriolar smooth muscle is also present in the primary cultures.

Local application of RGD peptides on the coverslip triggered propagation of Ca2+ waves traveling across the smooth muscle cell (Figs. 3 and 4). Because wave propagation did not depend on extracellular Ca2+, it suggests that the propagation is due to a regenerative release of Ca2+ from intracellular stores (22, 28). The propagation velocity of intracellular Ca2+ waves in the present study is in the range of 24-27 µm/s, which is faster than those observed in human vein smooth muscle cells (7.5 µm/s, induced by histamine; see Ref. 16), in the smooth muscle cell line A7r5 (16 µm/s, induced by vasopressin; see Ref. 1), and in human bronchial smooth muscle cells (18 µm/s, induced by arachidonic acid; see Ref. 6). This is the first report of integrin-mediated Ca2+ waves in smooth muscle cells. No other comparable data are available in the literature. The baseline fluorescence signal in the nucleus is in general lower than that of the cytoplasm, which indicates the existence of a nucleocytoplasmic Ca2+ gradient. The gradient was reversed when the cells were stimulated with RGD peptides. Similar observations of reversing the nucleocytoplasmic Ca2+ gradient were also reported in a smooth muscle cell line when stimulated by pharmacological agonists (12). Because the increase of nuclear [Ca2+]i was initiated when the cytoplasmic Ca2+ wave reached the nucleus, it is likely that the increase of nuclear [Ca2+]i is also the result of Ca2+-induced Ca2+ release. It is known that a mechanical signal can be transduced from the plasma membrane to the nucleus via the integrins and the cytoskeleton (14). If ligand binding on integrins had triggered a nuclear [Ca2+]i increase directly, the rise of nuclear [Ca2+]i would most likely have preceded the arrival of the cytoplasmic Ca2+ wave. The propagation of integrin-initiated Ca2+ waves was not limited to an individual cell. In some cases, it was observed that the wave propagated into the adjacent smooth muscle cells. The recurrent Ca2+ waves resulted in local oscillation of [Ca2+]i. The coupling of smooth muscles cells by Ca2+ oscillations might allow a population of cells to operate in unison to regulate myogenic tone (16). Interestingly, we have found that there are myogenic oscillations (vasomotion) in afferent arterioles, and an increase of transmural pressure induced by acute hypertension enhances the power of the vasomotion (25). These observations are consistent with the notion that there are oscillations of [Ca2+]i in renal vascular smooth muscle in vivo. Together with our previous observation that RGD-containing peptides can induce vasoconstriction in isolated afferent arterioles by increasing the vascular smooth muscle [Ca2+]i (27), the present study strongly suggests that integrins might be part of the signaling mechanism of the myogenic response in renal autoregulation.

Dihydropyridine-sensitive Ca2+ channels are abundant in renal arterioles (11) and are known to mediate Ca2+ influx in renal vascular smooth muscle. A patch-clamp study in smooth muscle cells isolated from cremaster muscle arterioles has suggested that exogenous RGD peptides modulate the activity of Ca2+ channels (24). Inhibition or stimulation of the Ca2+ current (measured by Ba2+ current) depends on which integrin heterodimers are ligated. However, the inability of nifedipine and depletion of extracellular Ca2+ to inhibit the increase of [Ca2+]i induced by GRGDSP in the present study suggests that the increase of [Ca2+]i is not the result of an extracellular Ca2+ influx but is due to the release of Ca2+ from intracellular stores. It is not surprising that smooth muscle cells from cremaster muscle arterioles and renal arterioles could employ very different Ca2+ signaling mechanism when ligands bind to integrins. RGD-containing peptides induce constriction in afferent arterioles but dilatation in cremaster skeletal arterioles (15, 27). Blocking of the IP3 receptor with xestospongin C had no effects on Ca2+ mobilization induced by RGD-containing peptides, but ryanodine completely abolished it. These observations strongly suggest that the increase of [Ca2+]i is due to the release of Ca2+ from ryanodine-sensitive Ca2+ stores and that the Ca2+ wave observed is due to Ca2+-induced Ca2+ release through ryanodine receptors. In the vascular smooth muscle cell line A7r5, the vasopressin-induced Ca2+ waves are mediated by IP3-sensitive Ca2+ stores (1).

The next hypothesis tested was whether specific interactions between RGD peptides and integrins are required for the elevation of [Ca2+]i. Antibodies against beta 1- and beta 3-integrins were chosen to test this hypothesis because these are the two most widely expressed integrin beta -subunits through which the extracellular matrix is connected to the cytoskeleton (5). Furthermore, a study in smooth muscle cells isolated from cremaster muscle arterioles has shown that exogenous RGD motifs increase the Ca2+ current via alpha 5beta 1-integrins and decrease the Ca2+ current via alpha vbeta 3-integrins (24). Immunofluorescence evidence from the present study indicates that these two beta -integrin subunits are also abundant in the primary cultures of renal vascular smooth muscle cells. Pretreatment with anti-beta 1- or anti-beta 3-integrin functional blocking antibodies totally abolished the elevation of [Ca2+]i triggered by the hexapeptide GRGDSP (Fig. 7). The inhibition could be due to the blocking of specific interactions between integrins and RGD motifs or deterioration of cellular physiological conditions. However, 1 µM phenylephrine still triggered an increase of [Ca2+]i even though the cells no longer responded to RGD peptides (data not shown), which indicates that the cells could still respond to a pharmacological agonist with mobilization of Ca2+. There was a transient decrease in the fluo 3 emission intensity when RGD peptides were introduced into the perfusion chamber (Fig. 7). This transient decrease (4-5 s) in emission intensity was due to the temporary dislocation of the coverslip from the focal plane during solution switching.

Ligation of either beta 1- or beta 3-integrin seems to be sufficient to induce Ca2+ mobilization. It is expected that blocking of both beta 1- and beta 3-integrin subunits is required to completely inhibit the effects of RGD peptides in [Ca2+]i. Our observations indicate that functional blocking of either beta 1 or beta 3 is sufficient to inhibit that. It might be because soluble RGD peptide is less efficient to ligate integrins compared with anti-integrin antibodies and/or the binding of functional blocking antibodies to beta 1-integrin reduces the binding affinity of beta 3 to soluble RGD peptides and vice versa. The observation that sequential application of these two antibodies both can trigger Ca2+ signaling is consistent with this notion. Recognition of integrin by anti-integrin antibodies does not depend on the RGD binding motifs.

Incubation of the smooth muscle cells with anti-beta 1- or anti-beta 3-integrin antibodies before cellular fixation resulted in very different immunofluorescence patterns of integrins when compared with preparations with cellular fixation before incubation with antibodies. The difference in immunofluorescence patterns suggests that there is a redistribution/clustering of integrins on the plasma membrane as a result of the occupancy by the functional-blocking antibodies. The redistribution and clustering of integrins in the plasma membrane might result in conceding the binding sites for RGD or changing the microenvironment of the RGD binding sites, which prevents the interactions of RGD with the beta -integrins. All of the above observations indicate that specific interactions between RGD peptides and integrins are required for the increase of [Ca2+]i in renal vascular smooth muscle cells. It is not certain whether the changes in [Ca2+]i are the result of the RGD-containing peptides interacting with free integrin on the cell surface or the result of the RGD peptides acting through inhibition of the attachment of the vascular smooth muscle cells to the collagen matrix (7). It can be a combination of both. These two events are not mutually exclusive. The end result of either mechanism is the formation of new ligand-integrin interactions. The anti-beta 1- or anti-beta 3-integrin antibodies can trigger Ca2+ mobilization in the presence of 0.1 mM GRGDSP (data not shown). By assuming that all free RGD binding sites have been occupied by GRGDSP at this condition, this observation indicates that inhibition of smooth muscle cell attachment is capable of mobilizing intracellular Ca2+.

Integrins are alpha beta -heterodimers. The integrin alpha -subunits associated with the beta 1- and beta 3-subunits to mediate the intracellular Ca2+ mobilization were not identified in this study. Wu et al. (24) have reported that Ca2+ current (measured by Ba2+ current) was enhanced by alpha 5beta 1-agonists and was reduced by alpha vbeta 3-agonists in smooth muscle cells isolated from cremaster muscle arterioles. However, our observations indicate that the Ca2+ mobilization in renal vascular smooth muscle does not depend on an influx of extracellular Ca2+. beta 1-Integrin can pair up a wide range of alpha -subunits, alpha 1 to alpha 9 and alpha v (3). beta 3-Integrin is most commonly paired with alpha v and alpha IIb (3). Identification of which heterodimer of integrins is involved in this signaling process will be the next step to elucidate the possible role of integrins in the mechanotransduction process of renal autoregulation (15, 27).

In summary, we have demonstrated that the hexapeptide GRGDSP induces an increase of [Ca2+]i in cultured renal vascular smooth muscle cells similar to that observed in smooth muscle cells of isolated afferent arterioles. Local application of GRGDSP could trigger a regenerative Ca2+ wave that propagates across the cell. The increase of intracellular [Ca2+]i depends on the Ca2+ released through ryanodine receptors and requires interactions of the RGD motif and integrins. Finally, the study is the first to show that RGD-containing peptides can trigger subcellular spatial and temporal variations in intracellular Ca2+.


    ACKNOWLEDGEMENTS

This study was supported by National Institutes of Health Grants DK-15968, HL-45623, and HL-59156.


    FOOTNOTES

Address for reprint requests and other correspondence: K.-P. Yip, Dept. of Physiology and Biophysics, College of Medicine, University of South Florida, MDC 8, 12901 Bruce B. Downs Blvd., Tampa, FL 33612 (E-mail: dyip{at}hsc.usf.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 12 August 1999; accepted in final form 20 September 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Blatter, LA, and Wier WG. Agonist-induced [Ca2+]i waves and Ca2+-induced Ca2+ releases in mammalian vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 263: H576-H586, 1992[Abstract/Free Full Text].

2.   Burner, M, Centeno G, Burki E, and Brunner HR. Confocal microscopy to analyse cytosolic and nuclear calcium in cultured vascular cell. Am J Physiol Cell Physiol 266: C1118-C1127, 1994[Abstract/Free Full Text].

3.   Cheresh, DA, and Mecham RP. Integrins Molecular and Biological Responses to the Extracellular Matrix. New York: Academic, 1994.

4.   Chon, KH, Chen YM, Marmarelis VZ, Marsh DJ, and Holstein-Rathlou N-H. Detection of interactions between myogenic and TGF mechanisms using nonlinear analysis. Am J Physiol Renal Fluid Electrolyte Physiol 267: F160-F173, 1994[Abstract/Free Full Text].

5.   Clark, EA, and Brugge JS. Integrins and signal transduction pathways: the road taken. Science 268: 233-239, 1995[ISI][Medline].

6.   Colliard-Rouiller, C, and Durand J. Arachidonic acid-induced calcium signalling in human airway smooth muscle cells. Respir Physiol 107: 263-273, 1997[ISI][Medline].

7.   D'Angelo, G, and Adam LP. Integrin-dependent modulation of vascular smooth muscle function (Abstract). Biophys J 78: 113A, 2000.

8.   D'Angelo, G, Mogford JE, Davis GE, Davis MJ, and Meininger GA. Integrin-mediated reduction in vascular smooth muscle [Ca2+]i induced by RGD-containing peptide. Am J Physiol Heart Circ Physiol 272: H2065-H2070, 1997[Abstract/Free Full Text].

9.   De Smet, P, Parys JB, Callewaert G, Weidema AF, Hill E, De Smedt H, Erneux C, Sorrentino V, and Missiaen L. Xestospongin C is an equally potent inhibitor of the inositol 1,4,5-triphosphate receptor and the endoplasmic-reticulum Ca2+ pumps. Cell Calcium 26: 9-13, 1999[ISI][Medline].

10.   Gebremedhin, D, Kaldunski M, Jacobs ER, Harder DR, and Roman RJ. Coexistence of two types of Ca2+-activated K+ channels in rat renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 270: F69-F81, 1996[Abstract/Free Full Text].

11.   Goligorsky, MS, Colflesh D, Gordienko D, and Moore LC. Branching points of renal resistance vessels are enriched in L-type calcium channels and initiate vasoconstriction. Am J Physiol Renal Fluid Electrolyte Physiol 268: F251-F257, 1995[Abstract/Free Full Text].

12.   Himpens, B, Smedt HD, Droogmans G, and Casteels R. Differences in regulation between nuclear and cytoplasmic Ca2+ in cultured smooth muscle cells. Am J Physiol Cell Physiol 263: C95-C105, 1992[Abstract/Free Full Text].

13.   Inscho, EW, Belott TP, Mason MJ, Smith JB, and Navar JG. Extracellular ATP increased cytosolic calcium in cultured rat renal arterial smooth muscle cells. Clin Exp Pharmacol Physiol 23: 503-507, 1997[ISI].

14.   Maniotis, AJ, Chen CS, and Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilized nuclear structure. Proc Natl Acad Sci USA 94: 849-854, 1997[Abstract/Free Full Text].

15.   Mogford, JE, Davis GE, Platts SH, and Meininger GA. Vascular smooth muscle alpha vbeta 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res 79: 821-826, 1996[Abstract/Free Full Text].

16.   Neylon, CB, Mason WT, and Irvine RF. Histamine-induced calcium oscillations in human vascular smooth muscle: temporal sequence and spatial organization in single cells. Clin Exp Pharm Physiol 18: 299-302, 1991[ISI][Medline].

17.   Phillips, DR, Charo IF, and Scarborough RM. GPIIb-IIIa: The responsive integrin. Cell 65: 359-362, 1991[ISI][Medline].

18.   Platts, SH, Mogford JE, Davis MJ, and Meininger GA. Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide. Am J Physiol Heart Circ Physiol 275: H1449-H1454, 1998[Abstract/Free Full Text].

19.   Roman, RJ, and Harder DR. Cellular and ionic signal transduction mechanisms for the mechanical activation of renal arterial vascular smooth muscle. J Am Soc Nephrol 4: 986-996, 1993[Abstract].

20.   Sanderson, MJ, Charles AC, Boitano S, and Dirksen ER. Mechanisms and function of intercellular calcium signaling. Mol Cell Endocrinol 98: 173-187, 1994[ISI][Medline].

21.   Springer, TA. Adhesion receptors of the immune system. Nature 346: 425-434, 1990[ISI][Medline].

22.   Tsien, RW, and Tsien RY. Calcium channels, stores, and oscillations. Annu Rev Cell Biol 6: 715-760, 1990[ISI].

23.   Wang, N, Butler JP, and Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124-1127, 1993[ISI][Medline].

24.   Wu, X, Mogford JE, Platts SH, Davis GE, Meininger GA, and Davis MJ. Modulation of calcium current in arteriolar smooth muscle by alpha vbeta 3 and alpha 5beta 1 integrin ligands. J Cell Biol 143: 241-252, 1998[Abstract/Free Full Text].

25.   Yip, K-P, Holstein-Rathlou N-H, and Marsh DJ. Mechanisms of temporal variation in single nephron blood flow in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 264: F427-F434, 1993[Abstract/Free Full Text].

26.   Yip, K-P, and Marsh DJ. [Ca2+]i in rat afferent arteriole during constriction measured with confocal fluorescence microscopy. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1004-F1011, 1996[Abstract/Free Full Text].

27.   Yip, K-P, and Marsh DJ. An Arg-Gly-Asp peptide stimulates constriction in rat afferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 273: F768-F776, 1997[Abstract/Free Full Text].

28.   Young, SH, Ennes HS, and Mayer EA. Propagation of calcium waves between colonic smooth muscle cells in culture. Cell Calcium 20: 257-271, 1996[ISI][Medline].

29.   Zhu, Z, and Arendshorst WJ. Angiotensin II-receptor stimulation of cytosolic calcium concentration in cultured renal resistance arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1239-F1247, 1996[Abstract/Free Full Text].


Am J Physiol Cell Physiol 280(3):C593-C603
0363-6143/01 $5.00 Copyright © 2001 the American Physiological Society